Brighton Jones’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$709K Buy
4,394
+193
+5% +$32.2K 0.01% 650
2026
Q2
$797K Buy
4,201
+290
+7% +$54.5K 0.01% 597
2026
Q1
$771K Buy
+3,911
New +$754K 0.02% 544
2025
Q4
– Sell
-3,429
Closed -$526K – 136
2025
Q3
$526K Buy
3,429
+28
+0.8% +$4.24K 0.01% 609
2025
Q2
$475K Buy
3,401
+515
+18% +$72.2K 0.01% 558
2025
Q1
$424K Sell
2,886
-5
-0.2% -$723 0.01% 441
2024
Q4
$379K Buy
2,891
+1,394
+93% +$195K 0.01% 462
2024
Q3
$233K Sell
1,497
-704
-32% -$114K 0.01% 495
2024
Q2
$343K Sell
2,201
-64
-3% -$9.6K 0.01% 443
2024
Q1
$307K Buy
2,265
+30
+1% +$3.97K 0.01% 459
2023
Q4
$301K Buy
2,235
+501
+29% +$65.1K 0.01% 444
2023
Q3
$235K Buy
1,734
+75
+5% +$10.2K 0.01% 463
2023
Q2
$237K Buy
+1,659
New +$244K 0.01% 460

Other funds holding AZN

Brighton Jones's AZN Position: Q3 2026 in Review

Brighton Jones increased its AstraZeneca (AZN) stake by 4.6% in Q3 2026, buying an estimated $32.2K and bringing the position to 4,394 shares worth $709K. The position accounts for 0.01% of the portfolio, ranked #650.

Brighton Jones first reported a position in AZN in Q2 2023 and has held it in 13 quarters since. The position peaked at $797K in Q2 2026. 1,242 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Brighton Jones held 4,394 shares of AstraZeneca worth $709K as of Q3 2026.
  • Brighton Jones bought 193 AstraZeneca shares in Q3 2026, an estimated $32.2K.
  • AstraZeneca made up 0.01% of Brighton Jones's portfolio in Q3 2026, its #650 holding.
  • Brighton Jones first reported a position in AstraZeneca in Q2 2023 and has held it in 13 quarters since.
  • Brighton Jones's AstraZeneca position peaked at $797K in Q2 2026.
  • 1,242 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.